Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Retroperitoneal Liposarcoma clinical trials
2 of 2 indexed Retroperitoneal Liposarcoma trials are currently recruiting.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count
Retroperitoneal Liposarcoma: 2 US clinical trials tracked, 2 recruiting.
Retroperitoneal Liposarcoma is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. The most active sponsor is Fox Chase Cancer Center, running 1 of these trials.
Enrollment posture brief
Registry condition retroperitoneal-liposarcoma
OPEN 2 | RECR 100% | LATE 0 | EARLY 0 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Retroperitoneal Liposarcoma lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Retroperitoneal Liposarcoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Retroperitoneal Liposarcoma is recruiting above its size-band peers.
2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma
Australia and New Zealand Sarcoma Association
NCT07377747
Genomic Risk in Retroperitoneal Sarcoma
Fox Chase Cancer Center
NCT06436846
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Retroperitoneal Liposarcoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Retroperitoneal Liposarcoma trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Retroperitoneal Liposarcoma page
2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Retroperitoneal Liposarcoma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Fox Chase Cancer Center sponsors the most Retroperitoneal Liposarcoma trials on record, review their full trial history before evaluating a specific study. See Fox Chase Cancer Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Retroperitoneal Liposarcoma condition card totals 2 registered trials; most-linked intervention Biospecimen sample collection during standard-of-care surgery; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.